235 related articles for article (PubMed ID: 29432123)
1. Catestatin Inhibits Obesity-Induced Macrophage Infiltration and Inflammation in the Liver and Suppresses Hepatic Glucose Production, Leading to Improved Insulin Sensitivity.
Ying W; Mahata S; Bandyopadhyay GK; Zhou Z; Wollam J; Vu J; Mayoral R; Chi NW; Webster NJG; Corti A; Mahata SK
Diabetes; 2018 May; 67(5):841-848. PubMed ID: 29432123
[TBL] [Abstract][Full Text] [Related]
2. The Effects of
Kim M; Seol MH; Lee BC
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31212747
[TBL] [Abstract][Full Text] [Related]
3. Catestatin (chromogranin A(352-372)) and novel effects on mobilization of fat from adipose tissue through regulation of adrenergic and leptin signaling.
Bandyopadhyay GK; Vu CU; Gentile S; Lee H; Biswas N; Chi NW; O'Connor DT; Mahata SK
J Biol Chem; 2012 Jun; 287(27):23141-51. PubMed ID: 22535963
[TBL] [Abstract][Full Text] [Related]
4. Pancreastatin-dependent inflammatory signaling mediates obesity-induced insulin resistance.
Bandyopadhyay GK; Lu M; Avolio E; Siddiqui JA; Gayen JR; Wollam J; Vu CU; Chi NW; O'Connor DT; Mahata SK
Diabetes; 2015 Jan; 64(1):104-16. PubMed ID: 25048197
[TBL] [Abstract][Full Text] [Related]
5. Hepatic TRAF2 regulates glucose metabolism through enhancing glucagon responses.
Chen Z; Sheng L; Shen H; Zhao Y; Wang S; Brink R; Rui L
Diabetes; 2012 Mar; 61(3):566-73. PubMed ID: 22315325
[TBL] [Abstract][Full Text] [Related]
6. Catestatin improves insulin sensitivity by attenuating endoplasmic reticulum stress:
Dasgupta A; Bandyopadhyay GK; Ray I; Bandyopadhyay K; Chowdhury N; De RK; Mahata SK
Comput Struct Biotechnol J; 2020; 18():464-481. PubMed ID: 32180905
[TBL] [Abstract][Full Text] [Related]
7. Catestatin induces glycogenesis by stimulating the phosphoinositide 3-kinase-AKT pathway.
Bandyopadhyay G; Tang K; Webster NJG; van den Bogaart G; Mahata SK
Acta Physiol (Oxf); 2022 May; 235(1):e13775. PubMed ID: 34985191
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D Receptor Activation in Liver Macrophages Ameliorates Hepatic Inflammation, Steatosis, and Insulin Resistance in Mice.
Dong B; Zhou Y; Wang W; Scott J; Kim K; Sun Z; Guo Q; Lu Y; Gonzales NM; Wu H; Hartig SM; York RB; Yang F; Moore DD
Hepatology; 2020 May; 71(5):1559-1574. PubMed ID: 31506976
[TBL] [Abstract][Full Text] [Related]
9. Myeloid-specific deletion of Zfp36 protects against insulin resistance and fatty liver in diet-induced obese mice.
Caracciolo V; Young J; Gonzales D; Ni Y; Flowers SJ; Summer R; Waldman SA; Kim JK; Jung DY; Noh HL; Kim T; Blackshear PJ; O'Connell D; Bauer RC; Kallen CB
Am J Physiol Endocrinol Metab; 2018 Oct; 315(4):E676-E693. PubMed ID: 29509432
[TBL] [Abstract][Full Text] [Related]
10. A new antidiabetic compound attenuates inflammation and insulin resistance in Zucker diabetic fatty rats.
Lu M; Patsouris D; Li P; Flores-Riveros J; Frincke JM; Watkins S; Schenk S; Olefsky JM
Am J Physiol Endocrinol Metab; 2010 May; 298(5):E1036-48. PubMed ID: 20159859
[TBL] [Abstract][Full Text] [Related]
11. Forkhead Box O6 (FoxO6) Depletion Attenuates Hepatic Gluconeogenesis and Protects against Fat-induced Glucose Disorder in Mice.
Calabuig-Navarro V; Yamauchi J; Lee S; Zhang T; Liu YZ; Sadlek K; Coudriet GM; Piganelli JD; Jiang CL; Miller R; Lowe M; Harashima H; Dong HH
J Biol Chem; 2015 Jun; 290(25):15581-15594. PubMed ID: 25944898
[TBL] [Abstract][Full Text] [Related]
12. Critical role of Kupffer cells in the management of diet-induced diabetes and obesity.
Neyrinck AM; Cani PD; Dewulf EM; De Backer F; Bindels LB; Delzenne NM
Biochem Biophys Res Commun; 2009 Jul; 385(3):351-6. PubMed ID: 19463788
[TBL] [Abstract][Full Text] [Related]
13. Histidine augments the suppression of hepatic glucose production by central insulin action.
Kimura K; Nakamura Y; Inaba Y; Matsumoto M; Kido Y; Asahara S; Matsuda T; Watanabe H; Maeda A; Inagaki F; Mukai C; Takeda K; Akira S; Ota T; Nakabayashi H; Kaneko S; Kasuga M; Inoue H
Diabetes; 2013 Jul; 62(7):2266-77. PubMed ID: 23474485
[TBL] [Abstract][Full Text] [Related]
14.
Na HY; Lee BC
Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30744038
[TBL] [Abstract][Full Text] [Related]
15. Macrophage migration inhibitory factor deficiency ameliorates high-fat diet induced insulin resistance in mice with reduced adipose inflammation and hepatic steatosis.
Finucane OM; Reynolds CM; McGillicuddy FC; Harford KA; Morrison M; Baugh J; Roche HM
PLoS One; 2014; 9(11):e113369. PubMed ID: 25412423
[TBL] [Abstract][Full Text] [Related]
16. Altered hepatic glucose homeostasis in AnxA6-KO mice fed a high-fat diet.
Cairns R; Fischer AW; Blanco-Munoz P; Alvarez-Guaita A; Meneses-Salas E; Egert A; Buechler C; Hoy AJ; Heeren J; Enrich C; Rentero C; Grewal T
PLoS One; 2018; 13(8):e0201310. PubMed ID: 30110341
[TBL] [Abstract][Full Text] [Related]
17. A novel benzenediamine derivative FC98 reduces insulin resistance in high fat diet-induced obese mice by suppression of metaflammation.
Chen C; Zhang W; Shi H; Zhuo Y; Yang G; Zhang A; Hou Y; Xiang Tan R; Li E
Eur J Pharmacol; 2015 Aug; 761():298-308. PubMed ID: 26086863
[TBL] [Abstract][Full Text] [Related]
18. Decreasing CB
Jourdan T; Nicoloro SM; Zhou Z; Shen Y; Liu J; Coffey NJ; Cinar R; Godlewski G; Gao B; Aouadi M; Czech MP; Kunos G
Mol Metab; 2017 Nov; 6(11):1517-1528. PubMed ID: 29107297
[TBL] [Abstract][Full Text] [Related]
19. Neprilysin deficiency reduces hepatic gluconeogenesis in high fat-fed mice.
Esser N; Mongovin SM; Mundinger TO; Barrow BM; Zraika S
Peptides; 2023 Oct; 168():171076. PubMed ID: 37572792
[TBL] [Abstract][Full Text] [Related]
20. The antagonist of CXCR1 and CXCR2 protects
Cui S; Qiao L; Yu S; Men L; Li Y; Li F; Du J
Am J Physiol Endocrinol Metab; 2019 Dec; 317(6):E1205-E1217. PubMed ID: 31573846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
